|
The purpose of the
conference is to
advance drug
discovery for
neurodegenerative
diseases by
educating scientists
on the process of
translating basic
research into novel
therapies.
Speakers and chairs
presented lectures
and case studies on:
Alzheimer’s disease,
Parkinson’s disease,
Huntington’s
disease,
Amyotrophic Lateral
Sclerosis (ALS), MS,
and other orphan
neurological
diseases.
The conference was
organized around the
following six
sub-topics:
I.
Basics of
Medicinal Chemistry
II.
Hits & Leads:
Early Phases of Drug
Discovery
III.
Pre-Clinical
Proof-of-Concept &
Development
IV.
Issues in Technology
Transfer:
Interactions and
Intellectual
Property
V.
Ask the Experts:
Drug Discovery
for Neurodegenerative
Disease
VI.
Resources and
Services For
Advancing Drug
Discovery
|
FINAL
PROGRAM - Review program details, speakers
and chair bios.